The Evaluation of Benzodiazepine Substances and Other Depressants, Drug Discrimination Assay

Status
Inactive
Published Date
October 10th, 2023
Response Deadline
October 20th, 2023
Location
VA, 22152, USA
Notice Type
Solicitation
Solicitation No.
15DDHQ23Q00000149

Buyer

JUSTICE, DEPARTMENT OFDRUG ENFORCEMENT ADMINISTRATIONHEADQUATERSSPRINGFIELD, VA, 22152, USA

PSC

SUPPORT- PROFESSIONAL: OPERATIONS RESEARCH/QUANTITATIVE ANALYSIS (R405)

Summary

The Justice Department of the Drug Enforcement Administration (DEA) is soliciting for the evaluation of Benzodiazepine substances and other depressants through a drug discrimination assay. This assay is typically used to determine the effects and characteristics of these substances, aiding in the identification and classification of drugs. The place of performance for this procurement is in Virginia (VA), USA, with a specific zip code of 22152. For any inquiries or submissions, the primary contact is Darrell Goodwin (darrell.goodwin@dea.gov) and the secondary contact is Nanaesi Amoo (nanaesi.amoo@dea.gov). The deadline for offers/quotations is extended to October 20, 2023, at 10:00 A.M.

Description

This RFQ Amendment No. 0001 is issued to establish be following: 1) DEA Q& A response to Vendor(s) questions. 2) Revision of the RFQ in accordance with DEA Q&A response. Note, all changes are cited in RED. 3) Revision of the Attachment 1 - Pricing Sheet Template. Note, all changes are cited in RED. 4) The hour and date for receipt of Offers/Quotations is extended to October 20, 2023 at 10:00 A.M.

Contact Information

PrimaryDarrell Goodwin
darrell.goodwin@dea.gov
SecondaryNanaesi Amoo
nanaesi.amoo@dea.gov
Attachments
20 KB
14 KB
20 KB
1.20 MB
1.92 MB